Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1057)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (19)
  8. Conference Paper (15)
  9. Correspondence (12)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2698)
  2. Department of Medicine (2698)
  3. Hematologic Malignancies, Division of (2698)
  4. Population Sciences Research Program (744)
  5. Survivorship Research (655)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (782)
  2. Steven Horwitz (666)
  3. Maria Palomba (445)
  4. Ariela Noy (371)
  5. David Straus (360)
  6. Alison Moskowitz (358)

More People

Years
  1. 2025 (45)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (876)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (83)
  5. British Journal of Haematology (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (941)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2698)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results
    Meeting Abstract

    Lunning, M. A.; Ruan, J.; Nair, S.; Boruchov, A. M.; Byrne, R.; Gerecitano, J. F.; Hamlin, P. A.; Inserra, B.; Leonard, J.; Lynch, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • CNS involvement in patients with AIDS-related lymphomas
    Meeting Abstract

    Joshi, J.; Mounier, N.; Xue, X. N.; Wang, D.; Ribera, J. M.; Wyen, C.; Dunleavy, K.; Little, R. F.; Wilson, W. H.; Noy, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with lymphoma: Prevalence and etiologies
    Meeting Abstract

    Goldfarb, S. B.; Jackson, T.; Carter, J.; Dickler, M. N.; Noy, A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQL) impact of idelalisib (IDELA) in patients (pts) with relapsed chronic lymphocytic leukemia (CLL): Phase 3 results
    Meeting Abstract

    Ghia, P.; O'Brien, S. M.; Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Barrientos, J. C.; Zelenetz, A. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Responses to romidepsin by line of therapy in patients with relapsed/refractory (R/R) peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Foss, F. M.; Pro, B.; Prince, H. M.; Sokol, L.; Greenwood, M.; Caballero, D.; Horwitz, S. M.; Coiffier, B.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safely of idelalisib (GS-1101) in combination with bendamustine and rituximab for previously treated chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Eradat, H. A.; Robak, T.; Delgado, J.; Schuh, A.; Pristupa, A. S.; Omyla-Staszewska, J.; Barrlentos, J. C.; Farber, C. M.; Macdonald, D.; Jacob, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab (R-InO) versus chemotherapy for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Dang, N. H.; Ogura, M.; Castaigne, S.; Fayad, L.; Jerkeman, M.; Radford, J. A.; Pezzutto, A.; Bondarenko, I.; Stewart, D. A.; Shnaidman, M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed CLL
    Meeting Abstract

    Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • US Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881)
    Meeting Abstract

    Barr, P. M.; Li, H. L.; Spier, C. M.; Mahadevan, D.; Friedberg, J. W.; LeBlanc, M. L.; Ul Haq, M.; Flowers, C.; Wagner-Johnston, N. D.; Cheson, B. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Adnexal mass secondary to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with associated amyloid deposition
    Journal Article

    Mehta, N.; Schòˆder, H.; Chiu, A.; Schoolmeester, J. K.; Portlock, C.
    BMJ Case Reports (2014)

    Fulltext@MSK | Save